← All Sponsors
SPONSOR

Otsuka Pharmaceutical Development & Commercialization, Inc.

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Phenylketonuria
NCT06971731 Phase 3
Recruiting

A Study to Evaluate the Safety and Efficacy of JNT-517 in Participants With Phenylketonuria (PKU)

Phenylketonuria
United States, Australia, France View Trial →